Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
Citi
Dow
US Department of Justice
Fish and Richardson
Teva
Mallinckrodt
McKesson

Generated: May 28, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019571

« Back to Dashboard

NDA 019571 describes HUMULIN U, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the HUMULIN U profile page.

The generic ingredient in HUMULIN U is insulin zinc susp extended recombinant human. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin zinc susp extended recombinant human profile page.
Summary for 019571
Tradename:HUMULIN U
Applicant:Lilly
Ingredient:insulin zinc susp extended recombinant human
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength40 UNITS/ML
Approval Date:Jun 10, 1987TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength100 UNITS/ML
Approval Date:Jun 10, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Cantor Fitzgerald
Moodys
Johnson and Johnson
Federal Trade Commission
Fish and Richardson
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.